Comparison of Biphozyl ® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation

Conditions:   Critically Ill;   Acute Kidney Injury;   Renal Replacement Therapy;   Continuous Renal Replacement Therapy;   Continuous Veno-Venous Hemofiltration;   Replacement Fluid;   Phoxilium;   Biphozyl;   Anticoagulation;   Regional Citrate Anticoagulation Interventions:   Drug: CVVH with Phoxilium® in the first 48h after randomization;   Drug: CVVH with Biphozyl® in the first 48h after randomization;   Drug: CVVH with Phoxilium® in the second 48h after randomization (after previous 48h with Biphozyl®);   Drug: CVVH with Biphozyl® in the second 48h after r andomization (after previous 48h with Phoxilium®) Sponsor:   Medical University Innsbruck Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials